SCHEMBL903415

SCHEMBL903415

CC(=O)C1=CCCC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22166415 0.86 ALDH1A1 (0.34)
SCHEMBL22060580 0.84 ALDH1A1 (0.33)
SCHEMBL172482 0.82
SCHEMBL149091 0.80
SCHEMBL14565969 0.80
SCHEMBL10160834 0.79 FFAR1 (0.33)
SCHEMBL14016192 0.78
SCHEMBL13057485 0.78
SCHEMBL11321495 0.78
SCHEMBL13024642 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113712885-A Anti-dropping hair-fixing extract liquid 优珀雅生物科技有限公司 2021-11-30 CN claimed
WO-2024030960-A2 COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS Kojin Therapeutics, Inc. (US) 2024-02-08 WO disclosed
WO-2023196991-A1 BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2023-10-12 WO disclosed
WO-2023165168-A1 APPLICATION OF PYRAZOLE DERIVATIVE AS β2 ADRENERGIC RECEPTOR ALLOSTERIC MODULATOR, ANTAGONIST AND AGONIST 常州大学 2023-09-07 WO disclosed
CN-115461327-A Spiro urea derivatives 爱杜西亚药品有限公司 2022-12-09 CN disclosed
CN-114712259-A Anti-hair loss and hair-fixing composition, preparation method and application product thereof 诺斯贝尔化妆品股份有限公司 2022-07-08 CN disclosed
CN-113712885-A Anti-dropping hair-fixing extract liquid 优珀雅生物科技有限公司 2021-11-30 CN disclosed
CN-113712885-A Anti-dropping hair-fixing extract liquid 优珀雅生物科技有限公司 2021-11-30 CN disclosed
EP-2652108-B1 DILUTABLE CONCENTRATED CLEANING COMPOSITION COLGATE PALMOLIVE CO (US) 2019-07-24 EP disclosed
WO-2019065283-A1 PYRIDAZINONE COMPOUND OR SALT THEREOF AND HERBICIDE CONTAINING SAME 石原産業株式会社 2019-04-04 WO disclosed
EP-2083014-A2 Inhibitors of interleukin-1ß converting enzyme Vertex Pharmceuticals Incorporated (US) 2009-07-29 EP disclosed
US-7491494-B2 Evolving new molecular function PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2009-02-17 US disclosed
EP-1343503-B1 HETEROARYL UREA NEUROPEPTIDE Y Y5 RECEPTOR ANTAGONISTS SCHERING CORP (US) 2008-11-12 EP disclosed
US-20070043208-A1 Crystal structure of erythrocyte binding domain of EBA-175 NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2007-02-22 US disclosed
EP-1392644-A1 CINNAMIDE DERIVATIVES AS KCNQ POTASSIUM CHANNEL MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-03-03 EP disclosed
WO-2002096858-A1 CINNAMIDE DERIVATIVES AS KCNQ POTASSIUM CHANNEL MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-12-05 WO disclosed
EP-0639554-A1 Process for the preparation of propargyl ethers BAYER AG (DE) 1995-02-22 EP disclosed
US-5250742-A Process for the production of propargyl ethers and new propargyl ethers BAYER AKTIENGESELLSCHAFT (DE) 1993-10-05 US disclosed
EP-0523475-A1 Propargyl ethers and process for their preparation BAYER AG (DE) 1993-01-20 EP disclosed
EP-0114389-A2 Substituted arylglyoxal derivatives AMERICAN CYANAMID COMPANY (US) 1984-08-01 EP disclosed